-
1
-
-
35348890215
-
Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes
-
Abbo A., Carmeli Y., Navon-Venezia S., Siegman-Igra Y., Schwaber M.J. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 2007, 26:793-800.
-
(2007)
Eur J Clin Microbiol Infect Dis
, vol.26
, pp. 793-800
-
-
Abbo, A.1
Carmeli, Y.2
Navon-Venezia, S.3
Siegman-Igra, Y.4
Schwaber, M.J.5
-
2
-
-
57649234918
-
Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance program
-
Mendes R.E., Bell J.M., Turnidge J.D., Castanheira M., Jones R.N. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance program. J Antimicrob Chemother 2009, 63:55-59.
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 55-59
-
-
Mendes, R.E.1
Bell, J.M.2
Turnidge, J.D.3
Castanheira, M.4
Jones, R.N.5
-
3
-
-
35848952749
-
Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study
-
Lee N.Y., Wang C.L., Chuang Y.C., Yu W.L., Lee H.C., Chang C.M., et al. Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study. Pharmacotherapy 2007, 27:1506-1511.
-
(2007)
Pharmacotherapy
, vol.27
, pp. 1506-1511
-
-
Lee, N.Y.1
Wang, C.L.2
Chuang, Y.C.3
Yu, W.L.4
Lee, H.C.5
Chang, C.M.6
-
4
-
-
67649729676
-
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
-
Principe L., D'Arezzo S., Capone A., Petrosillo N., Visca P. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob 2009, 8:18.
-
(2009)
Ann Clin Microbiol Antimicrob
, vol.8
, pp. 18
-
-
Principe, L.1
D'Arezzo, S.2
Capone, A.3
Petrosillo, N.4
Visca, P.5
-
5
-
-
37849040424
-
Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
-
Pankuch G.A., Lin G., Seifert H., Appelbaum P.C. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob Agents Chemother 2008, 52:333-336.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 333-336
-
-
Pankuch, G.A.1
Lin, G.2
Seifert, H.3
Appelbaum, P.C.4
-
6
-
-
24744455886
-
In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii
-
Kiffer C.R., Sampaio J.L., Sinto S., Oplustil C.P., Koga P.C., Arruda A.C., et al. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii. Diagn Microbiol Infect Dis 2005, 52:317-322.
-
(2005)
Diagn Microbiol Infect Dis
, vol.52
, pp. 317-322
-
-
Kiffer, C.R.1
Sampaio, J.L.2
Sinto, S.3
Oplustil, C.P.4
Koga, P.C.5
Arruda, A.C.6
-
7
-
-
0034061105
-
In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak
-
Appleman M.D., Belzberg H., Citron D.M., Heseltine P.N., Yellin A.E., Murray J., et al. In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak. Antimicrob Agents Chemother 2000, 44:1035-1040.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 1035-1040
-
-
Appleman, M.D.1
Belzberg, H.2
Citron, D.M.3
Heseltine, P.N.4
Yellin, A.E.5
Murray, J.6
-
8
-
-
1442349053
-
Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates
-
Jung R., Husain M., Choi M.K., Fish D.N. Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 2004, 48:1055-1057.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 1055-1057
-
-
Jung, R.1
Husain, M.2
Choi, M.K.3
Fish, D.N.4
-
9
-
-
32644481380
-
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units
-
Timurkaynak F., Can F., Azap O.K., Demirbilek M., Arslan H., Karaman S.O. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 2006, 27:224-228.
-
(2006)
Int J Antimicrob Agents
, vol.27
, pp. 224-228
-
-
Timurkaynak, F.1
Can, F.2
Azap, O.K.3
Demirbilek, M.4
Arslan, H.5
Karaman, S.O.6
-
10
-
-
0029800028
-
Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test
-
White R.L., Burgess D.S., Manduru M., Bosso J.A. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 1996, 40:1914-1918.
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 1914-1918
-
-
White, R.L.1
Burgess, D.S.2
Manduru, M.3
Bosso, J.A.4
-
11
-
-
42549104674
-
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology
-
Falagas M.E., Karageorgopoulos D.E. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008, 46:1121-1122.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1121-1122
-
-
Falagas, M.E.1
Karageorgopoulos, D.E.2
-
12
-
-
77954955056
-
-
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI
-
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
-
(2009)
-
-
-
13
-
-
0033802358
-
Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods
-
Bonapace C.R., White R.L., Friedrich L.V., Bosso J.A. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagn Microbiol Infect Dis 2000, 38:43-50.
-
(2000)
Diagn Microbiol Infect Dis
, vol.38
, pp. 43-50
-
-
Bonapace, C.R.1
White, R.L.2
Friedrich, L.V.3
Bosso, J.A.4
|